Literature DB >> 3595322

The cat infected with Brugia pahangi as a model of human filariasis.

D A Denham, C Fletcher.   

Abstract

The responses of cats to Brugia pahangi, which parasitizes them in nature, mimic those of humans to Brugia malayi and Wuchereria bancrofti in many important respects. It is likely that many of the features of the relationship between host and parasite that can be studied in cats infected with B. pahangi also apply to humans, but for a variety of practical reasons cannot be demonstrated in humans. Both immunologically and parasitologically there is a profound difference between B. pahangi-infected cats that have microfilariae in their blood and those that either do not become microfilaraemic or clear their blood of microfilariae and become post-microfilaraemic. Microfilaraemic cats are susceptible to reinfection and fail to recognize the surface of the sheath of microfilariae. They also do not produce antibodies against several components recognized by post-microfilaraemic cats. Cats that have destroyed their microfilariae also destroy their adult worms and are very resistant to challenge with infective larvae. Apart from the unique ability to recognize the sheath of microfilariae in fluorescent antibody tests, sera from these cats react with microfilarial antigens at 61-81 kDa, antigens of infective larvae at 22 and 18.5 kDa and adult antigens at 34, 18, 16, 13 and 11.5 kDa. None of these antigens are recognized by microfilaraemic cats.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595322     DOI: 10.1002/9780470513446.ch15

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  9 in total

1.  Isolation and characterization of three subpopulations of IgG in the common cat (Felis catus).

Authors:  C I Baldwin; D A Denham
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

2.  Modelling variability in lymphatic filariasis: macrofilarial dynamics in the Brugia pahangi--cat model.

Authors:  E Michael; B T Grenfell; V S Isham; D A Denham; D A Bundy
Journal:  Proc Biol Sci       Date:  1998-01-22       Impact factor: 5.349

3.  In vivo transfection of developmentally competent Brugia malayi infective larvae.

Authors:  Shulin Xu; Canhui Liu; George Tzertzinis; Elodie Ghedin; Christopher C Evans; Ray Kaplan; Thomas R Unnasch
Journal:  Int J Parasitol       Date:  2010-11-28       Impact factor: 3.981

4.  Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.

Authors:  P S Turaga; T J Tierney; K E Bennett; M C McCarthy; S C Simonek; P A Enyong; D W Moukatte; S Lustigman
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

5.  Modulation of cellular and humoral immunity, and disease manifestation during onset of patency in Brugia pahangi-infected dogs.

Authors:  D Schreuer; B Hammerberg
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

6.  B1 B lymphocytes play a critical role in host protection against lymphatic filarial parasites.

Authors:  N Paciorkowski; P Porte; L D Shultz; T V Rajan
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

7.  Development of a toolkit for piggyBac-mediated integrative transfection of the human filarial parasite Brugia malayi.

Authors:  Canhui Liu; Amruta S Mhashilkar; Johan Chabanon; Shulin Xu; Sara Lustigman; John H Adams; Thomas R Unnasch
Journal:  PLoS Negl Trop Dis       Date:  2018-05-21

8.  In vivo imaging of transgenic Brugia malayi.

Authors:  Canhui Liu; Sai Lata De; Kristi Miley; Thomas R Unnasch
Journal:  PLoS Negl Trop Dis       Date:  2020-04-03

9.  CRISPR-mediated Transfection of Brugia malayi.

Authors:  Canhui Liu; Alexandra Grote; Elodie Ghedin; Thomas R Unnasch
Journal:  PLoS Negl Trop Dis       Date:  2020-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.